$KYMR 4 SEC Filings

Filed On	Filing
01 Oct 2026	Form 4: Mainolfi Nello, Director Received 30,000 shares by exercise or conversion ($62.4K) · Sold 30,000 shares ($3.41M)
04 Sep 2026	Form 4: Adams Brian, Chief Legal Officer Sold 6,371 shares ($744K)
27 Jul 2026	Form 4: Rooney Terence, Chief Medical Officer Received 38,000 shares as a grant or award · Granted 76,000 Stock Option (Right to Buy)
07 Jul 2026	Form 4: Mainolfi Nello, Director Received 50,000 shares by exercise or conversion ($104K) · Sold 50,000 shares ($5.95M)
02 Jul 2026	Form 4: Jacobs Bruce N., Chief Financial Officer Received 61,378 shares by exercise or conversion ($327K) · Sold 77,109 shares ($8.86M)
02 Jul 2026	Form 4: Goodman Noah, Chief Business Officer Sold 3,389 shares ($387K)
02 Jul 2026	Form 4: Mainolfi Nello, Director Received 80,000 shares by exercise or conversion ($166K) · Sold 80,000 shares ($9.22M)
30 Jun 2026	Form 4: Booth Bruce, Director Sold 31,283 shares ($3.42M)
30 Jun 2026	Form 4: Booth Bruce, Director Sold 467,878 shares ($51.6M) · Sold 45,367 shares ($4.86M)
26 Jun 2026	Form 4: Bvf Partners L P/IL, Director and 9 others Sold 1,630,658 shares ($174M)
25 Jun 2026	Form 4: Booth Bruce, Director Sold 285,684 shares ($34.8M)
25 Jun 2026	Form 4: Booth Bruce, Director Sold 1,408 shares ($141K) · Sold 134,720 shares ($13.5M) · Sold 262,637 shares ($30.3M)
25 Jun 2026	Form 4: Bvf Partners L P/IL, Director and 9 others Granted 6,068 Stock Option (Right to Buy)
25 Jun 2026	Form 4: Booth Bruce, Director Granted 6,068 Stock Option (Right to Buy)
25 Jun 2026	Form 4: Hrustanovic Gorjan, Director Granted 6,068 Stock Option (Right to Buy)
25 Jun 2026	Form 4: Goodman Noah, Chief Business Officer Received 5,000 shares by exercise or conversion ($105K) · Sold 5,000 shares ($570K)
25 Jun 2026	Form 4: Albers Jeffrey W., Director Granted 6,068 Stock Option (Right to Buy)
25 Jun 2026	Form 4: Ridloff Elena, Director Granted 6,068 Stock Option (Right to Buy)
25 Jun 2026	Form 4: Sandor Victor, Director Granted 6,068 Stock Option (Right to Buy)
25 Jun 2026	Form 4: Maraganore John, Director Granted 6,068 Stock Option (Right to Buy)

Comments